The periorbital area — skin of the eyelids and under-eye region — is the thinnest skin on the body (approximately 0.5mm vs 1.5–2mm elsewhere on the face), making it the first site to show visible aging signs: fine lines, crepiness, puffiness, and the complex phenomenon of dark circles. The "eye cream" category is one of the most marketed in skincare, yet clinical evidence for most proprietary eye cream formulations is thin. Understanding the actual causes of under-eye concerns guides rational product selection — not all dark circles are the same. Our skin care catalog includes clinical-grade periorbital care products.
Dark Circles: Three Distinct Causes
Periorbital dark circles have three primary mechanisms requiring different approaches: (1) Vascular/hemosiderin — visible blood through thin translucent skin, or hemosiderin staining from microhemorrhage degradation — appears bluish-purple and worsens with fatigue and fluid shifts. Treatment: caffeine (vasoconstriction and lymphatic drainage stimulation), vitamin K (theoretical hemosiderin reduction — evidence modest), retinol (increasing skin thickness reducing vascular visibility). (2) Pigmentary — true melanin hyperpigmentation in the periorbital area, more common in darker Fitzpatrick types and post-inflammatory patterns — appears brownish and consistent in color. Treatment: niacinamide, kojic acid, vitamin C, azelaic acid — the same depigmenting agents used elsewhere on the face. (3) Structural/shadow — tear trough volume loss creating hollow and shadow. Treatment: topical therapy is ineffective — hyaluronic acid fillers placed at the tear trough by trained injectors are the appropriate treatment.
What Actually Works in Eye Creams
For periorbital skin aging (fine lines, thin skin, crepiness): retinol (0.025–0.1% — lower than facial concentrations due to thin skin sensitivity) has the strongest evidence for fine line improvement; ceramide-rich formulations support barrier function; peptides (acetyl hexapeptide-3/Argireline for dynamic wrinkle reduction, palmitoyl peptides for collagen stimulation) have clinical evidence at appropriate concentrations; growth factors and EGF may provide skin quality improvement. The active ingredient concentrations matter: many "eye creams" provide insufficient concentrations to produce biological effects. A well-formulated retinol facial serum applied carefully to the periorbital area (avoiding the lid margin) may outperform expensive dedicated eye creams with lower active concentrations.
